INVO Bioscience, Inc. (INVO) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by INVO Bioscience, Inc. on September 20, 2024, covering events reported on September 18, 2024. The Company is incorporated in Nevada and its common stock trades on The Nasdaq Capital Market under the symbol "INVO".
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or debt figures for the current period. However, it addresses a material accounting error regarding the valuation of right-of-use (ROU) assets and lease liabilities. The Company confirmed that this error impacted only balance sheet assets and liabilities. It explicitly stated that the error did not impact revenue, results of operations, earnings (loss) per share, or net equity.
Material Changes and Events
- Nasdaq Delisting Notice: The Company received notice from Nasdaq that it failed to maintain the minimum bid price of $1.00 per share for 34 consecutive business days, violating Listing Rule 5550(a)(2).
- Compliance Period: The Company has an initial 180-day period (until May 17, 2025) to regain compliance. Compliance is achieved if the stock closes at or above $1.00 for 10 consecutive business days.
- Financial Restatement: The Audit Committee determined that previously issued financial statements from June 30, 2021, through June 30, 2024, should no longer be relied upon. This follows an internal review prompted by SEC comments regarding the incorrect use of federal rates instead of incremental borrowing rates for lease valuations.
Outlook, Risks, and Management Commentary
Management intends to file amended reports containing restated financial statements. The Company will monitor its stock price and consider available options, including a reverse stock split, to regain Nasdaq compliance. There is no assurance that the Company will regain compliance or avoid delisting if the minimum bid price requirement is not met within the allotted periods. The Company retains the right to appeal a delisting determination to a Nasdaq hearings panel.
Investor Verification Checklist
- Verify the current trading price of INVO stock relative to the $1.00 minimum bid requirement.
- Monitor upcoming filings for the amended financial statements reflecting the lease liability restatement.
- Track the Company's progress toward the May 17, 2025, compliance deadline.
- Review any future announcements regarding a potential reverse stock split.